Mary Gail Mercurio, MD
Dermatology · Rochester, NYNPI 1447287008
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $1,300 of the $1,966 with a category attached, or 66.1%. 9 manufacturers reported payments, led by Cepheid at 33.1% of the total. Reporting peaked in 2021 at $755 and has fallen 69.2% since, to $233 in 2025. That places this record below the midpoint for dermatology clinicians in NY, where the typical reported total is $2,360.
Across 11 payments — averaging $178.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cepheid$650
- AbbVie$650
- Sanofi$177
- Novartis$140
- Johnson & Johnson$130
- Genentech USA, Inc.$85
- plus $134 from 3 others
Across 53 payments — averaging $12,331 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$537K
- Sun Pharmaceutical Industries Inc.$78K
- Pfizer$39K
What the payments were for
- Speaking & faculty fees$1,30066%
- Food & beverage$59330%
- Education$734%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cepheid | 1 | $650 |
| AbbVie | 1 | $650 |
| Sanofi | 3 | $177 |
| Novartis | 1 | $140 |
| Johnson & Johnson | 1 | $130 |
| Genentech USA, Inc. | 1 | $85 |
| Regeneron Healthcare Solutions, Inc. | 1 | $73 |
| Strata Skin Sciences, Inc. | 1 | $41 |
| Incyte Corporation | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,966 in reported general payments places this provider in the 45th percentile of 1,151 dermatology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 22 | $255 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Rochester
- Lisa BeckRochester$755K
- Alexandra GolantNew York$3.6M
- David CohenNew York$3M
- Michael CameronNew York$2.6M
- Saakshi KhattriNew York$2.4M
- Amy WechslerNew York$2.4M
- Jeffrey WeinbergKew Gardens$2.3M
- Joshua ZeichnerNew York$2.1M
- Russell CohenOceanside$2.1M
- Jeffrey LaducaAuburn$1.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.